Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Prostaglandin-Endoperoxide Synthase. Found 7 abstracts

Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Badawi AF, Liu Y, Eldeen MB, Morrow W, Razak ZR, Maradeo M, Badr MZ. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate. Carcinogenesis. 2004 Sep;25(9):1681-8.
Badawi AF, Badr MZ. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review). Int J Oncol. 2002 Jun;20(6):1109-22.
Badawi AF, Habib SL, Mohammed MA, Abadi AA, Michael MS. Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer. Cancer Invest. 2002 Jan;20(5-6):651-6.
Lu S, Zhang X, Badawi AF, El-Sohemy A, Archer MC. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids. Cancer letters. 2002 Oct 08;184(1):7-12.
Yang WL, Frucht H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis. 2001 Sep;22(9):1379-83.
Yang WL, Frucht H. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells. Carcinogenesis. 2000 Oct;21(10):1789-93.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Prostaglandin-Endoperoxide Synthase

Prostaglandin-Endoperoxide Synthase Isoenzymes US Gov't Support-PHS Female Human Cyclooxygenase Inhibitors Dinoprostone physiology Apoptosis Cytoplasmic and Nuclear Receptors pharmacology antagonists & inhibitors Rats genetics enzymology Transcription Factors biosynthesis Experimental Mammary Neoplasms Drug Dose-Response Relationship US Gov't Support-Non-PHS therapeutic use Male HT29 Cells EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Methylnitrosourea Sprague-Dawley Rats Drug Synergism 0 (Isoenzymes) Cell Division pathology metabolism Sulfonamides Anticarcinogenic Agents me [Metabolism] en [Enzymology] Neoplastic Gene Expression Regulation Messenger RNA 363-24-6 (Dinoprostone) Prostate drug effects cytology Neoplasm RNA N-Methylscopolamine Muscarinic Agonists Prostaglandin D2 physiopathology Colonic Neoplasms Carbachol Animal ge [Genetics] adverse effects ci [Chemically Induced] 0 (Transcription Factors) cdc Genes Enzymologic Gene Expression Regulation ad [Administration & Dosage] Down-Regulation Case-Control Studies agonists Antineoplastic Agents 0 (Bax protein) Thiazoles pd [Pharmacology] EC 2-7-1-37 (Protein Kinase C) 61-90-5 (Leucine) 0 (Proto-Oncogene Proteins c-bcl-2) de [Drug Effects] pc [Prevention & Control] Muscarinic Receptors Proto-Oncogene Proteins Up-Regulation Polymerase Chain Reaction Cell Cycle DNA Fragmentation Biological Markers Non-US Gov't Support chemically induced Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) 0 (Biological Markers) ag [Agonists] Fluorenes Muscarinic Antagonists 0 (Proto-Oncogene Proteins) Protein Kinase C 169590-42-5 (celecoxib) 0 (Cyclooxygenase Inhibitors) Middle Age EC 1-14-99 (cyclooxygenase 2) Reference Values Unsaturated Fatty Acids 684-93-5 (Methylnitrosourea) Dietary Fats Tretinoin toxicity aa [Analogs & Derivatives] Disease Susceptibility Breast Neoplasms Aged Inbred F344 Rats EC 1-14-99-1 (cyclooxygenase 2) Leucine EC 2-7-1 (protein kinase C alpha) ph [Physiology] administration & dosage Tissue Culture Aging Carcinogens 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Unsaturated Dietary Fats Smoking 0 (Sulfonamides) 41598-07-6 (Prostaglandin D2) Bladder Neoplasms 0 (Fluorenes) Messenger) 0 (RNA ai [Antagonists & Inhibitors] control Colon prevention & control bi [Biosynthesis] Proto-Oncogene Proteins c-bcl-2 0 (15-deoxyprostaglandin J2) Urothelium 0 (Anticarcinogenic Agents) Prostaglandins pa [Pathology] prevention & Reverse Transcriptase Polymerase Chain Reaction Enzyme-Linked Immunosorbent Assay Non-Steroidal Anti-Inflammatory Agents
Last updated on Monday, August 10, 2020